Because the results are inconclusive, we meta-analyzed the available literature to gain a comprehensive status of the diagnostic usefulness of the f/t PSA ratio in prostate carcinoma when patients had total serum prostate-specific antigen between 4 and 10 ng/mL. This evidence concerns the gene KLK3 and prostate carcinoma.